Jacqueline Glover, 24, has Dravet syndrome, a severe and rare type of epilepsy marked by prolonged seizures and increased risk of sudden death.

Tamara 'Tats' Ward, from Middle Barton in Oxfordshire, has raised more than £500,000 for the charity Dravet Syndrome UK over ...

On Sunday, she ran the Royal Parks Half Marathon in London on Sunday whilst hula hooping - sealing a new world record in the ...

UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...

Long-term data on the treatment of children and adults living with Lennox-Gastaut syndrome (LGS) with fenfluramine1 demonstrated sustained reduction in frequency of seizures associated with a fall and ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

A Pride of Britain finalist from Middle Barton will look to set a new world record when she takes part in a half marathon in London this weekend.

US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...

Needham raised the firm’s price target on Stoke Therapeutics (STOK) to $35 from $22 and keeps a Buy rating on the shares. The company presented ...

U.S. Rep. Chuck Edwards spoke to his District 11 constituents in Flat Rock, Brevard and Saluda. These are the concerns they ...

OVID reported positive phase 1 results for OV329, a next-generation GABA-AT inhibitor targeting drug-resistant focal onset ...